GENERAL DATUM Becomes Technology Transferee of BioAlpha, Strengthening India’s Alpha Irradiation Capabilities
GENERAL DATUM has achieved a major milestone by becoming a Technology Transferee of the Automated Alpha Particle Irradiator – BioAlpha, a specialized innovation developed and certified by the Bhabha Atomic Research Centre. This development reinforces the company’s commitment to advancing cutting-edge research technologies within India.
The Automated Alpha Particle Irradiator represents a highly niche and critical technology, with limited availability globally for studying the biological and material effects of alpha radiation. Through this technology transfer, GENERAL DATUM has undertaken the advancement of BioAlpha into a compact, efficient, and application-ready system designed to meet the evolving needs of modern research environments.
The system has been engineered with enhanced capabilities, including compatibility with hypoxia chambers and incubator-based setups, enabling precise and controlled experimental conditions. Its automated design improves repeatability, operational efficiency, and safety key requirements in advanced radiation research.
Speaking on this development, leadership at GENERAL DATUM emphasized the strategic importance of the initiative in strengthening indigenous technological capabilities and enabling high-impact scientific research in India.
This milestone aligns with the organization’s long-term vision of driving deep-tech innovation, research and development, and self-reliance in critical technologies. By integrating advanced engineering with scientific research needs, GENERAL DATUM continues to contribute to the expansion of India’s deep-tech ecosystem.
The successful transfer and enhancement of BioAlpha marks a significant step toward making sophisticated alpha irradiation technology more accessible, scalable, and practical for researchers and institutions across the country.